AMRX
AMRX's valuation is historically cheap while fundamentals are somewhat mixed and the outlook is broadly stable, though analyst coverage is limited.
AMRX vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 35x | 218x | 84% lower-84% |
| PE percentile | 24 | 50 | 53% lower-53% |
| EPS | $0.49 | -$0.25 | $0.74 higher+$0.74 |
| FCF | $83.1M | $182.7M | 55% lower-55% |
| Loading historical comparisons… | |||
AMRX’s fundamentals are mixed relative to their historical averages, while its earnings multiple is lower.
AMRX Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Stable |
| Forward earnings | Stable |
| Forward revenue | Stable |
| Forward profitability | Strongly expanding |
| Analyst coverage | Limited |
| Estimate dispersion | Tight |
AMRX’s outlook is generally stable, though analyst coverage is limited.
AMRX PE Valuation
This table applies AMRX's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
AMRX Earnings Per Share
This chart tracks AMRX's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
AMRX Quarterly Revenue
This chart tracks AMRX's quarterly revenue over time and shows how sales are changing from year to year.
AMRX Free Cash Flow
This chart tracks AMRX's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
AMRX Total Shares
This chart tracks changes in AMRX's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
AMRX Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
AMRX PE vs Healthcare Sector
This chart compares AMRX's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
AMRX Weekly Price
This chart uses AMRX's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
AMRX Weekly Moving Averages
This chart compares AMRX's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
AMRX Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.
HIMS
HIMS's valuation appears fair, fundamentals are somewhat mixed, while forward estimates point to a return to profit and improving margins, though analyst coverage is limited and estimates vary widely.
HIMS vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 50x | 81x | 39% lower-39% |
| PE percentile | 21 | 50 | 58% lower-58% |
| EPS | -$0.63 | -$0.12 | $0.50 lower-$0.50 |
| FCF | $89.9M | $42.3M | 112% higher+112% |
| Loading historical comparisons… | |||
HIMS’s fundamentals are mixed relative to their historical averages, while its earnings multiple is lower.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | -- |
| Forward earnings | Turning positive |
| Forward revenue | Strong growth |
| Forward profitability | Strongly expanding |
| Analyst coverage | Limited |
| Estimate dispersion | Wide |
HIMS’s outlook is generally improving, supported by an expected return to profitability.
HIMS PE Valuation
This table applies HIMS's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
HIMS Earnings Per Share
This chart tracks HIMS's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
HIMS Quarterly Revenue
This chart tracks HIMS's quarterly revenue over time and shows how sales are changing from year to year.
HIMS Free Cash Flow
This chart tracks HIMS's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
HIMS Total Shares
This chart tracks changes in HIMS's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
HIMS Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
HIMS PE vs Healthcare Sector
This chart compares HIMS's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
HIMS Weekly Price
This chart uses HIMS's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
HIMS Weekly Moving Averages
This chart compares HIMS's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
HIMS Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.